P349 A NEW ANKLE CONDRAL LESIONS CLASSIFICATION -  by Di Cave, E. et al.
S188 Poster Presentations
analgesic medication, VAS range was required to be between
40 mm and 90 mm. Lastly, all subjects were required to have a
Body Mass Index < 35.
For this multiple baseline, repeated measures design, all sub-
jects were evaluated for 3 baseline visits at 2 week intervals.
At the third baseline visit, subjects were then given an 8-week
course of celecoxib (200 mg/d). Outcome measures continued
to be collected at 2 week intervals during the 8 week course
of medication. At each of the seven total visits, subjects com-
pleted the VAS version of the Western Ontario and McMaster
Universities Osteoarthritis Index (WOMAC) pain, stiffness and
function scales; performed three trials of the Timed Up and Go
Test (TUG); and walked 24 feet for five trials across a com-
puterized gait mat that recorded velocity, cadence, step length,
and double support time. Means from all tests were calcu-
lated for each visit. The baseline values were averaged to more
accurately assess function prior to beginning medication. This
baseline value and data from the four bi-weekly medication ses-
sions were entered into one-way repeated measures ANOVAs
to determine within-group differences for each of the dependent
variables (p = 0.05). Paired t-tests were employed for post hoc
analyses.
Results: Results of the ANOVA indicated that subjects signifi-
cantly increased walking velocity (p=.029) and cadence (p=.001),
with post hoc tests indicating significant differences from base-
line at week 8 for velocity and weeks 6 and 8 for cadence. While
modest improvements occurred in step lengths and double limb
support time, the differences were not statistically significant. All
subjects significantly improved on their TUG scores (p=.009) and
on all aspects of the WOMAC (function: p=.005, pain: p=.019,
stiffness: p=.001).
Conclusions: Walking velocities improved steadily during the
eight week course of celecoxib. We believe the faster walking
speeds resulted because subjects took more steps rather than
longer steps. The effect of the medication on reducing symptoms
of pain and stiffness may account for a greater freedom of limb
movement, whereby subjects could more freely advance their
lower limbs, take additional steps, and improve efficiency of their
walking.
In addition to symptomatic relief of pain and stiffness, subjects
improved in all aspects of their walking performance. These
positive findings also support the use of a clinically-based, in-
strumented gait analysis to determine the effectiveness of this
medication on walking function in individuals with knee OA.
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Purpose: Aim of this study has been the identification of a
treatment algorythm based on the proposal a new ankle chondral
lesion classification, that took in consideration the need to better
localize, understand and commonly relate the different chondral
lesions patterns, diagnosed on MRI and confirmed and treated
by ankle arthroscopy, both in the distal tibia and in the talar
dome. Last ten years dilemma in such lesions treatment has
focused on talus lesions staging, that, in our opinion represents
just the 2/3 of the problem, neglecting the thorough examination
of the distal tibia articular surface lesions.
Methods: Initially we needed to create a classification of carti-
lage ankle lesions in order to identify a common language both
for the diagnosis then the planning and treatment of the le-
sions.One of the main problems to solve was that of evaluating,
beyond the talus lesions, until now considered alone, the distal
tibia extremity lesions wich until now have been in impingement
classification. We therefore searched for the most adequate and
homogeneous classification to answer the needs of foot and an-
kle surgeons in daily practice, searching for common parameters
between MRI -CT- RDX - Arthroscopic findings
Results: The goal of the classification we have developed proved
to be very usefull in the planning of the correct corresponding
surgical treatment.
As reported in the lecterature early detection and treatment
facilitates better outcome.
This is not only confirmed by our study, but we have found that
talus lesion starting from ll degree is very often associated to
a minor tibial plafond lesion, often understimated, secondary to
microinstability or to axial malalignement that in our experience
has required an associated high tibial osteotomy.
Conclusions: The rationale of this classification consists in
giving each lesion a precise identification of position subdiving in
A tibia, B talus as main lesions, 1-2-3 medial third, medial, lateral
third, "a" tibia and "b" talus as secondary lesions (were present)
We felt that it was important to mantain the classification of
Berndt and harty with regards to the depth and the anatomo-
pathological lesions found.
For the staging of the lesions with the new classification the
following will be used:
es. grade A2blll to define a lesion that has main localization
the tibia, the medial position, secondary localization in the talus
dome and grading of the lesion lll.
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Purpose: Whole body vibration (WBV) has been proposed as
an effective exercise intervention because of its potential for
increasing force generating capacity in the lower limbs, and
a training effect on the neuromuscular system. Knee OA is
associated with decreased muscular strength and neuromuscular
function in the lower extremities. The aim of this study was to
evaluate whether WBV would be able to improve muscle function
of the lower extremities and balance and to improve the patients
pain and physical signs of knee OA. In addition two different
WBV devices were compared, one with vibration alone (VibMax)
and one with vibration combined with the demand of keeping the
body equilibrium during WBV (ViBrosFär).
Methods: 52 female patients with knee OA, fulfilling the ACR-
criteria, volunteered to participate in this study. Their mean age
was 60.5 years (SD 9.9) and their mean Body Mass Index
was 28.8 kg/m2 (SD 4.5). Patients with other chronic diseases
or artificial knee or hip joint were excluded from the study.
Before randomization, the proprioception (measured as knee
joint position sense, JPS and threshold to detection of a passive
movement, TDPM), ability to climb up and downstairs on time,
walking on time, standing balance on a force plate and isometric
muscle strength was measured. In addition the patients filled in
the SF-36 and WOMAC questionnaires. Patients randomized to
either ViBrosfär (balance plate with laterally vibration, 24 - 30
Hz, 1-2 mm amplitude, Vibrosfär, ProMedVi, Sweden) or VibMax
(stable plate with both laterally and vertical vibration, 25-30 Hz,
1 1/2-4 mm amplitude, Vibmax, Xendon, Sweden) exercised two
times per week for eight weeks. The exercise progression was
standardized and equal for both exercise groups. A third group
acted as control group.
Results: Baseline values of proprioception showed a total mean
for all three groups of JPS: 5.5° (SD 2.6°) and for TDPM: 2.6°
(SD 1.1°); total mean for all three groups for climbing six steps
